Cellular oncology (Dordrecht) : Impact Factor & More
eISSN: 2211-3436pISSN: 2211-3428
Share this on:
Key Metrics
CiteScore 
9.7
SNIP
1.27
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Cellular oncology (Dordrecht) Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1989 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Cellular oncology (Dordrecht) ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cellular oncology (Dordrecht)
Targeting PRMT5 to reshape the immune microenvironment and reverse Trop2 ADC resistance in triple-negative breast cancer
- 4 Aug 2026
- Cellular Oncology
Deciphering the regulatory role of ADAM8 in the PDAC tumor microenvironment
- 3 Aug 2026
- Cellular Oncology
Targeting RPRD1B overcomes chemoresistance in gastric cancer by suppressing the TOPBP1-mediated DNA damage repair pathway
- 2 Aug 2026
- Cellular Oncology
From cystogenesis to carcinogenesis in ADPKD: risk modeling and a multistep precision surveillance
- 29 Jul 2026
- Cellular Oncology
Mitochondrial stress-induced cuproptosis: a metabolic bridge to reprogramming the GBM immune microenvironment.
- 20 Jul 2026
- Cellular oncology (Dordrecht, Netherlands)
RNA-binding protein RALYL-mediated BCL11B RNA stability promotes immune escape in small cell lung cancer through transcriptional activation of BUB3.
- 15 Jul 2026
- Cellular oncology (Dordrecht, Netherlands)
Targeting PRMT5 to reshape the immune microenvironment and reverse Trop2 ADC resistance in triple-negative breast cancer
- 4 Aug 2026
- Cellular Oncology
Deciphering the regulatory role of ADAM8 in the PDAC tumor microenvironment
- 3 Aug 2026
- Cellular Oncology
Targeting RPRD1B overcomes chemoresistance in gastric cancer by suppressing the TOPBP1-mediated DNA damage repair pathway
- 2 Aug 2026
- Cellular Oncology
From cystogenesis to carcinogenesis in ADPKD: risk modeling and a multistep precision surveillance
- 29 Jul 2026
- Cellular Oncology
Mitochondrial stress-induced cuproptosis: a metabolic bridge to reprogramming the GBM immune microenvironment.
- 20 Jul 2026
- Cellular oncology (Dordrecht, Netherlands)
RNA-binding protein RALYL-mediated BCL11B RNA stability promotes immune escape in small cell lung cancer through transcriptional activation of BUB3.
- 15 Jul 2026
- Cellular oncology (Dordrecht, Netherlands)
FAQs on Cellular oncology (Dordrecht)
How long has Cellular oncology (Dordrecht) been actively publishing? 
What is the publishing frequency of Cellular oncology (Dordrecht)?
How many articles did Cellular oncology (Dordrecht) publish last year?
What is the eISSN & pISSN for Cellular oncology (Dordrecht)?
What is Citescore for Cellular oncology (Dordrecht)?
What is SNIP score for Cellular oncology (Dordrecht)?
Who is the publisher of Cellular oncology (Dordrecht)?
